Cours Chinook Tyee Industry Ltd Toronto S.E.
Actions
GBI.H
CA16961T2083
Produits pharmaceutiques
CA 2021 | 453 k 329 k 302 k | CA 2022 | - | Capitalisation | 3,43 M 2,49 M 2,29 M |
---|---|---|---|---|---|
Résultat net 2021 | -3 M -2,18 M -2 M | Résultat net 2022 | -1 M -726 k -667 k | VE / CA 2021 | 24,5 x |
Dette nette 2021 | 1,87 M 1,36 M 1,25 M | Dette nette 2022 | 3,15 M 2,28 M 2,1 M | VE / CA 2022 | - |
PER 2021 |
-2,14
x | PER 2022 |
-1,79
x | Employés | - |
Rendement 2021 * |
-
| Rendement 2022 |
-
| Flottant | 74,11% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Tom Kusumoto
CEO | Chief Executive Officer | 54 | 14/12/12 |
Director/Board Member | 72 | 05/12/18 | |
Investor Relations Contact | - | 01/01/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Tom Kusumoto
CEO | Chief Executive Officer | 54 | 14/12/12 |
Director/Board Member | 72 | 05/12/18 | |
Frank Otto
BRD | Director/Board Member | - | 11/05/22 |
Varia. 1 janv. | Capi. | |
---|---|---|
+39,33% | 6,01 Md | |
-18,38% | 4,4 Md | |
-9,17% | 3,17 Md | |
+3,98% | 3,07 Md | |
-3,41% | 2,51 Md | |
+48,74% | 1,88 Md | |
-4,82% | 1,73 Md | |
-1,24% | 1,65 Md | |
-8,96% | 1,58 Md |